Obesity and type 2 diabetes: understanding the role of ethnicity

被引：0
|
作者：
Olsson, T. [1 ]
Goedecke, J. H. [2 ]
机构：
[1] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden
[2] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa
来源：
JOURNAL OF INTERNAL MEDICINE | 2020年 / 288卷 / 03期
关键词：
ethnicity; obesity; type; 2; diabetes;
D O I：
10.1111/joim.13043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This is an article from the symposium: Berzelius symposium: Obesity and Type 2 Diabetes: Understanding the Role of Ethnicity
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [41] Obesity and type 2 diabetes
    Toplak, Hermann
    Hoppichler, Friedrich
    Wascher, Thomas C.
    Schindler, Karin
    Ludvik, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S196 - S200
  • [42] Type 1 diabetes, obesity and PCOS: Is type 1 stepping into the shoes of type 2 diabetes?
    Codner, Ethel
    CLINICAL ENDOCRINOLOGY, 2021, 95 (02) : 265 - 266
  • [43] Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
    Blachnio-Zabielska, Agnieszka
    Hajduch, Eric
    Le Stunff, Herve
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [44] Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes
    Davis, N.
    Forbes, B.
    Wylie-Rosett, J.
    MINERVA MEDICA, 2009, 100 (03) : 221 - 228
  • [45] Association of genetic variants for susceptibility to obesity with type 2 diabetes in Japanese individuals
    Takeuchi, F.
    Yamamoto, K.
    Katsuya, T.
    Nabika, T.
    Sugiyama, T.
    Fujioka, A.
    Isono, M.
    Ohnaka, K.
    Fujisawa, T.
    Nakashima, E.
    Ikegami, H.
    Nakamura, J.
    Yamori, Y.
    Yamaguchi, S.
    Kobayashi, S.
    Ogihara, T.
    Takayanagi, R.
    Kato, N.
    DIABETOLOGIA, 2011, 54 (06) : 1350 - 1359
  • [46] THE ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN OBESITY-ASSOCIATED TYPE 2 DIABETES IN MICE
    Saksida, Tamara
    Stosic-Grujicic, Stanislava
    Stojanovic, Ivana
    ARCHIVES OF BIOLOGICAL SCIENCES, 2013, 65 (02) : 499 - 505
  • [47] DIABETES AND OBESITY. THE ROLE OF AGONISTS GLUCAGON-LIKE PEPTIDE-1 OF IN THE TREATMENT OF TYPE 2 DIABETES
    Petunina, Nina A.
    Telnova, Milena E.
    DIABETES MELLITUS, 2018, 21 (04): : 293 - 300
  • [48] Practical strategies to manage obesity in type 2 diabetes
    Rodbard, Helena W.
    Barnard-Kelly, Katharine
    Pfeiffer, Andreas F. H.
    Mauersberger, Carina
    Schnell, Oliver
    Giorgino, Francesco
    DIABETES OBESITY & METABOLISM, 2024, 26 (06) : 2029 - 2045
  • [49] Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
    Reeves, Helen L.
    Zaki, Marco Y. W.
    Day, Christopher P.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1234 - 1245
  • [50] Gut microbiota and therapy for obesity and type 2 diabetes
    Zhang, Luyao
    Wang, Pai
    Huang, Juan
    Xing, Yanpeng
    Wong, F. Susan
    Suo, Jian
    Wen, Li
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345